-
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsHsu JJ, Ziaeian B, Fonarow GC. -
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJ Tromp, L Shen, PS Jhund et al.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
-
Mechanical circulatory support devices in advanced heart failure: 2020 and beyondJL Vieira, HO Ventura, MR Mehra et al.
-
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureB Bozkurt, AJS Coats, H Tsutsui et al.
-
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJanuzzi JL Jr, Richards AM.
-
Mechanical circulatory support devices for acute right ventricular failureKapur NK, Esposito ML, Bader Y et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
